GlobeNewswire

Atsena Therapeutics Announces Upcoming Presentations at Scientific and Medical Meetings
23/04/2026
DURHAM, N.C., April 23, 2026 (GLOBE NEWSWIRE) -- Atsena Therapeutics, a clinical-stage gene therapy company focused on using the life-changing power of genetic medicine to reverse or prevent blindness, today announced [...]
Theialife Appoints Thomas Ruggia as President and Chief Executive Officer to Advance Phase-3 Ready Oral Myopia Therapy and Scale Ophthalmology Platform
23/04/2026
DOVER, Del., April 23, 2026 (GLOBE NEWSWIRE) -- Theialife, a late-stage clinical company advancing innovative therapeutic solutions for ocular diseases, today announced the appointment of Thomas Ruggia as President and [...]
CorTec’s Brain Interchange™ Accepted into FDA Total Product Life Cycle Advisory Program (TAP)
23/04/2026
Third patient successfully implanted at Harborview Medical Center as NIH-funded stroke trial advances Freiburg, Germany, April 23, 2026 (GLOBE NEWSWIRE) -- CorTec GmbH today announced that the U.S. Food and Drug [...]
Belite Bio to Participate in Four Upcoming Investor Conferences
23/04/2026
SAN DIEGO, April 23, 2026 (GLOBE NEWSWIRE) -- Belite Bio , Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative [...]
Leo International Precision Health AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
23/04/2026
Leo International Precision Health AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] 23. Apr 2026 / 14:00 CET/CEST, [...]
GB HealthWatch Launches AI-Ready Genetic Reports for the GB Longevity100 Suite
23/04/2026
AI-powered innovation transforms complex genetic data into clear, actionable insights for clinicians and individuals SAN DIEGO, April 23, 2026 (GLOBE NEWSWIRE) -- GB HealthWatch today announced the launch of an AI-ready [...]
Marvel Biosciences to Participate and Present at the 2nd Neuroscience Innovation Partnering and Licensing Summit
23/04/2026
CALGARY, Alberta, April 23, 2026 (GLOBE NEWSWIRE) -- Marvel Biosciences Corp. (TSXV: MRVL | OTC: MBCOF ), and its wholly-owned subsidiary, Marvel Biotechnology Inc. (collectively “Marvel” or the “Company” ), a [...]
Plus Therapeutics Initiates Manufacturing Activities with SpectronRx Under a Master Services Agreement to Support GMP Pivotal Trial Readiness for REYOBIQ™
23/04/2026
HOUSTON, April 23, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for [...]
Corvus Pharmaceuticals Appoints Andrew C. Chan, M.D., Ph.D., to Board of Directors
23/04/2026
SOUTH SAN FRANCISCO, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, announced today that Andrew C. Chan, M.D., Ph.D., has been [...]
Helus Pharma Strengthens Scientific Advisory Board with Addition of Dr. Robert Langer and Dr. Stephen Brannan
23/04/2026
Addition of globally recognized leaders in translational science and clinical development as the Company advances its pipeline towards key inflection points NEW YORK and TORONTO, April 23, 2026 (GLOBE NEWSWIRE) -- Helus [...]
Aurora Spine Corporation Schedules Release of Fourth Quarter and Fiscal 2025 Financial Results
23/04/2026
CARLSBAD, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in the development of groundbreaking medical devices for spinal [...]
The Joint Corp. to Report 2026 First Quarter Results on Thursday, May 7 and Host Conference Call and Webcast
23/04/2026
SCOTTSDALE, Ariz., April 23, 2026 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest franchisor of chiropractic care through The Joint Chiropractic ® network, announced it will report its 2026 [...]
Ocugen to Present at April 2026 Investor and Industry Conferences
23/04/2026
MALVERN, Pa., April 23, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that Dr. Shankar Musunuri [...]
Kymera Therapeutics to Report First Quarter 2026 Financial Results on April 30, 2026
23/04/2026
WATERTOWN, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological [...]
Conavi Medical Awarded 2026 TAG Innovation Award
23/04/2026
Recognition Follows FDA 510(k) Clearance of its Next-Generation Hybrid Intravascular Imaging System TORONTO, April 23, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (“Conavi” or the “Company”) (TSXV: CNVI; OTCQB: CNVIF [...]
Genenta signs Definitive Agreements with Sophia High Tech
23/04/2026
Genenta enters aerospace as it continues its strategic transformation into a next-generation industrial consolidator MILAN,Italy, April 23, 2026 (GLOBE NEWSWIRE) -- Genenta Science S.p.A. (Nasdaq: GNTA), evolving into [...]
Antag Therapeutics to present data on AT7687, its first-in-class GIPR antagonist peptide at the American Diabetes Association’s 2026 Scientific Sessions
23/04/2026
Copenhagen, Denmark, 23 April 2026 – Antag Therapeutics (“Antag” or “the Company”), advancing personalized and flexible obesity treatment through GIP receptor antagonism, today announces that it will deliver an oral [...]
Radiopharm Theranostics Reports Business Update
23/04/2026
Completed enrolment in Phase 2b clinical trial of imaging agent RAD 101 in patients with recurrent brain metastases following earlier announcement of interim data demonstrating concordance with MRI (the primary endpoint [...]
Jade Biosciences Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
23/04/2026
SAN FRANCISCO and VANCOUVER, British Columbia, April 23, 2026 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade” or the “Company”) (Nasdaq: JBIO), a clinical-stage biotechnology company focused on developing best-in- [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum